Panbesy is a popular drug for treatment of morbid obesity approved in Singapore, Hong Kong and South Korea. Panbesy is available in capsules that contain 15 mg or 30 mg of Phentermine Hydrochloride (HCl).
Panbesy capsules have a colorless transparent body and dark blue cap with a white marking “P 30” or “P 15” depending on the dosage strength. Panbesy is available in plastic bottles that contain 30 or 100 of the original capsules.
A Swiss company Osmopharm is the owner of the rights to manufacture Panbesy. The following companies have the right to distribute this drug for obesity treatment:
- Lf Asia, which has been supplying Panbesy to the Hong Kong market since 1990;
- Euro Asia Medico, which has been supplying Panbesy to Singapore’s pharmaceutical market since 1989;
- Al bojen Korea, which has been distributing Panbesy in South Korea since 2007.